Advanced Oncotherapy Current EV significantly below cumulative investment to date (VIDEO)

Advanced Oncotherapy (LON:AVO) is the topic of conversation when Dr Martin Hall, Analyst at Hardman & Co joins DirectorsTalk.

Martin updates us on some of the recent developments at the company, explains why the share price is languishing, the demand for the project, shares his thoughts on the success of LIGHT and the company valuation.

Advanced Oncotherapy plc is a UK-based company focused on delivering a cost-effective proton-based radiotherapy solution called LIGHT. Based on ground-breaking technology developed and tested at world renowned CERN in Switzerland, the LIGHT system delivers an integrated proton radiotherapy system to treat cancer.

You might also enjoy reading H&T Group Unique opportunities for strong, profitable growth (VIDEO)

Find more news, interviews, share price & company profile here for:

Hardman & Co

You can also listen to our interviews on:

Share this interview

Want to share this interview on a forum? Use this forum friendly link: https://1lo.co/BR0Kc

Other Interviews

Oakley Capital Investments 2022 Results: EBITDA Growth Drives NAV Appreciation (VIDEO) March 29, 2023
H&T Group Unique opportunities for strong, profitable growth (VIDEO) March 27, 2023
Apax Global Alpha 2022 results adding value to companies leads to outperformance (VIDEO) March 21, 2023
Pantheon International Long-term out-performance from exceptional companies (VIDEO) March 15, 2023
Fidelity European Trust still outperforming its peer group over all time scales (VIDEO) March 13, 2023
Fidelity Asian Values Opportunities from India (VIDEO) March 1, 2023
Real Estate Credit Investments – Opportunities in uncertain times (VIDEO) February 27, 2023
ICG Enterprise Trust Defensive growth adding value to investors (VIDEO) February 23, 2023
Volta Finance scenario testing showing 20%+ IRR in all likely scenarios (VIDEO) January 27, 2023
Apax Global Alpha adding value to private companies (VIDEO) January 23, 2023

More News

Fidelity European Trust outperforms peers for dividend income investing March 15, 2023
Real Estate Credit Investments portfolio yield has risen by a tenth in recent months (LON:RECI) December 5, 2022
Fidelity European Trust resilience pays dividends LON:FEV (VIDEO) December 2, 2022
Performance, prospects and risks analysed for Fidelity Asia investment trust (LON:FAS) November 21, 2022
Income investing stock Volta Finance cash flows at near-record levels (LON:VTA) October 13, 2022
Asia market dynamics gives favourable tailwinds to Fidelity Asian Values investment trust (LON: FAS) (VIDEO) July 22, 2022
Volta Finance huge diverse portfolio with good long-term cashflows (Analyst VIDEO) July 15, 2022
Fidelity European Trust – Key strengths to weather headwinds (Analyst VIDEO) April 29, 2022
Asia investment opportunity: FAS trust success in disciplined Fidelity approach April 19, 2022
CyanConnode revenue opportunity hundreds of millions (Analyst Interview) February 21, 2022

Ask your questions

Do you have questions you’d like to ask this company, get in touch and we’ll ask them for you.

I have questions

Useful links

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

© 2023 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.